Literature DB >> 2184787

Eradication of bancroftian filariasis by diethylcarbamazine-medicated common salt on Little Kinmen (Liehyu district), Kinmen (Quemoy) Islands, Republic of China.

P C Fan1.   

Abstract

Since bancroftian filariasis constituted a major public health problem on Little Kinmen (Liehyu District), Kinmen (Quemoy) Islands, a control programme was conducted on this island from 1970 to 1982. A pre-control survey recorded a microfilarial rate (mfr) of 9.6%, a night blood microfilarial density (mfd) of 14.4/20 microliters blood, and a clinical rate of 26.2%. Culex quinquefasciatus was found to be the only vector of the parasitosis on the island, with an infection rate (Ir) with all filarial larval stages of 9.1% and a larval density (Ld) of 6.2. Diethylcarbamazine (DEC)-medicated salt (0.33% w/w) was administered to the whole population on Little Kinmen. Each person was estimated to take 12.7 g salt with 42 mg DEC daily for six months (July-December 1974). All accepted the programme, and no adverse side-effect was noted. During the control, the mfr and mfd were reduced to 0.3% and 1.9/20 microliters blood. The Ir and Ld were reduced to 0.8% and 1.3. Eight post-control surveys (1975-1982) revealed only two of 459 pre-control carriers positive and the remaining population of 7125 inhabitants negative. The two carriers were cured with a course of 5 g DEC. All family members of these carriers and their neighbours' families were given DEC-medicated salt for four months to clear the only remaining source of filarial transmission. In addition to a reduction in the prevalence of filariasis in humans and in mosquitoes to zero, the clinical manifestations disappeared in 52.4% of the pre-control carriers and improved in 19.0%. There was no change in 19.8 and 8.7% had new manifestations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184787     DOI: 10.1080/00034983.1990.11812430

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  6 in total

1.  Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis.

Authors:  Patrick Lammie; Trevor Milner; Robin Houston
Journal:  Bull World Health Organ       Date:  2007-07       Impact factor: 9.408

2.  Elimination of diurnally sub-periodic Wuchereria bancrofti in Andaman and Nicobar Islands, India, using mass DEC-fortified salt as a supplementary intervention to MDA.

Authors:  A N Shriram; Addepalli Premkumar; K Krishnamoorthy; Amitabha De; S K Paul; S Subramanian; P Vijayachari; P Jambulingam
Journal:  Parasitol Res       Date:  2020-03-26       Impact factor: 2.289

3.  Current evidence on the use of antifilarial agents in the management of bancroftian filariasis.

Authors:  Sumadhya Deepika Fernando; Chaturaka Rodrigo; Senaka Rajapakse
Journal:  J Trop Med       Date:  2010-12-30

4.  Cross-strait parasitological research priorities arrived at by historical tracking and advanced dialogue.

Authors:  Jyh-Wei Shin; Jia-Xu Chen; Dong-Hui Zhang; Wei-Chen Lin; Bo Shen; Min-Jun Ji
Journal:  Infect Dis Poverty       Date:  2014-12-01       Impact factor: 4.520

5.  Assessing endgame strategies for the elimination of lymphatic filariasis: A model-based evaluation of the impact of DEC-medicated salt.

Authors:  Morgan E Smith; Brajendra K Singh; Edwin Michael
Journal:  Sci Rep       Date:  2017-08-07       Impact factor: 4.379

6.  Economic performance and cost-effectiveness of using a DEC-salt social enterprise for eliminating the major neglected tropical disease, lymphatic filariasis.

Authors:  Swarnali Sharma; Morgan E Smith; James Reimer; David B O'Brien; Jean M Brissau; Marie C Donahue; Clarence E Carter; Edwin Michael
Journal:  PLoS Negl Trop Dis       Date:  2019-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.